Synthetic protein potentially improves outcomes for select intracerebral hemorrhage patients

Results from the largest-ever clinical trial of its kind found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding following a type of stroke called an intracerebral hemorrhage (ICH).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup